http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60130512-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13acffa0e4ce30d3be128ccd86b384f6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
filingDate | 1983-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f61237e841e681f576540dd7398778c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f68f00ac829dfceb964b1ae911dba91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806055cdfa06933dd558d9f04dd2b18d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb2bfb55ce4a99921b6f6e6748d12bd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f1816fb8143b80436ce2bbbb34d40a2 |
publicationDate | 1985-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S60130512-A |
titleOfInvention | Tape pharmaceutical for treating dermatopathy |
abstract | PURPOSE: The titled pharmaceutical, obtained by forming a high polymer layer capable of exhibiting tackiness at ordinary temperature on a carrier having flexibility, and incorporating or applying bleomycin hydrochloride, etc. exhibiting remarkable effect on skin cancer, etc. to the layer, and capable of suppressing side effects of the above-mentioned chemical by percutaneous administration. n CONSTITUTION: A tape pharmaceutical, obtained by forming a high polymer layer which is preferably a copolymer of (a) 50W99wt% (meth)acrylic acid ester having a 4W14C alkyl group and (b) 1W50wt% at least one monomer copolymerizable with the above-mentioned ester having tackiness at ordinary temperature, and incorporating or applying bleomycin hydrochloride (or sulfate) exhibiting remarkable effect on dermal malignant tumors, e.g. epithelial cancer or melanoma, to the above-mentioned layer, and capable of treating by direct application to the integument of local diseases with percutaneous absorption of the above-mentioned chemical. A constant amount of the above-mentioned chemical can be percutaneously administered without loss by the above-mentioned pharmaceutical, and improved remedial effect can be exhibited without side effects. n COPYRIGHT: (C)1985,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07505375-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0395119-A |
priorityDate | 1983-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.